We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+63.19%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$464M
AUM Growth
+$174M
Cap. Flow
-$3.63M
Cap. Flow %
-0.78%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$3.63M

Sector Composition

Rank Sector Weight
1 Communication Services 71.24%
2 Consumer Discretionary 27.33%
3 Healthcare 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAS
1
DELISTED
Integral Ad Science
IAS
$324M 69.83%
22,722,771
– –
DKNG icon
2
DraftKings
DKNG
$11.4B
$127M 27.33%
6,555,608
– –
VRDN icon
3
Viridian Therapeutics
VRDN
$2.13B
$5.33M 1.15%
209,505
– –
ROKU icon
4
Roku
ROKU
$21.1B
$3.8M 0.82%
57,707
– –
SNAP icon
5
Snap
SNAP
$7.32B
$2.75M 0.59%
245,559
– –
LRMR icon
6
Larimar Therapeutics
LRMR
$416M
$1.32M 0.29%
292,184
– –
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-574,996
Closed -$3.63M

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Atlas Venture Advisors held 7 positions worth $464M, up 60% from $290M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors's Q1 2023 filing shows 1 closed position. The largest sale was F-star Therapeutics, Inc. Common Stock, an estimated $3.63M.

By sector, the portfolio is most concentrated in Communication Services at 71% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Atlas Venture Advisors fully exited F-star Therapeutics, Inc. Common Stock in Q1 2023, selling an estimated $3.63M.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $464M portfolio in Q1 2023.
  • Atlas Venture Advisors opened 0 new positions and closed 1 in Q1 2023.
  • Atlas Venture Advisors's portfolio value rose 60% quarter-over-quarter to $464M.

Based on Atlas Venture Advisors's 13F filing for Q1 2023, filed 8 May 2023.